Veraxa Biotech’s Secarna partnership milestone expands conjugation market potential
Veraxa Biotech says a Secarna partnership milestone opens a new potential market for conjugation technology.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.